Spearmint supplement for thinking skills in children with Down syndrome
Part of Brain & nervous system, Genetic & congenital clinical trials.
This study tests a natural compound from spearmint (called K110-42) to see if it helps improve attention and thinking in children with Down syndrome. Children aged 4–8 take the supplement daily for a while, and researchers monitor their cognitive skills.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child must have a confirmed genetic test showing Down syndrome (Trisomy 21).
- Your child should be between 4 and 8 years old.
- Your child should have some trouble with attention or focus—you may have noticed this or a doctor may have seen it.
- Your child cannot have other major conditions like autism, epilepsy, or serious health problems (liver, kidney, heart, cancer, etc.).
- Your child must not be on ADHD stimulant medicines or brain-boosting supplements, and must not have an underactive thyroid (hypothyroidism).
- Your child should not be allergic to spearmint or the supplement ingredients.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a drug called memantine can help people with Down syndrome. It aims to see if it's safe and if it improves memory or thinking.
This study tests whether a daily sage extract supplement can improve thinking, focus, and memory in healthy middle-aged adults. If it works, it could offer a natural way to support brain health.
This trial studies whether a GnRH hormone treatment can improve thinking and memory in people with Down syndrome. It also checks safety and whether the treatment affects brain-related changes seen on MRI.
This trial is testing whether a form of vitamin B3 (called NAD) can help prevent or slow down Alzheimer's disease in people with Down syndrome. The goal is to see if this supplement can protect brain cells and improve memory or thinking.
This study tests if an investigational drug called AEF0217 can help improve thinking and daily living skills in people with Down syndrome. It's for ages 16-32 who have a caregiver to support them throughout the trial.
This trial checks whether a “NIH Toolbox” set of child-friendly tests can detect changes when stimulant medicine is used for ADHD. It may help doctors better measure how well stimulant treatment is working in people with intellectual disability.
Hear when a new Cognitive Functions trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.